Literature DB >> 16979412

Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.

Christian Carpéné1, Danièle Daviaud, Jeremie Boucher, Sandy Bour, Virgile Visentin, Sandra Grès, Carine Duffaut, Emi Fontana, Xavier Testar, Jean-Sébastien Saulnier-Blache, Philippe Valet.   

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) is known to increase during in vitro adipogenesis and to be one of the most highly expressed membrane proteins of white adipocytes. Although less well documented, mitochondrial monoamine oxidases (MAOs) are also present in adipocytes and share with SSAO the capacity to generate hydrogen peroxide. This work therefore aimed to compare several biologic effects of MAO and SSAO substrates in 3T3-F442A adipocytes. In differentiated cells, tyramine oxidation was predominantly MAO dependent, whereas benzylamine oxidation was SSAO dependent. Both amines partially mimicked insulin actions, including stimulation of Akt phosphorylation and glucose uptake. In addition, tyramine and benzylamine impaired tumor necrosis factor alpha-dependent nitric oxide formation in a pargyline- and semicarbazide-sensitive manner, respectively. Various biogenic amines were tested in competition for tyramine or benzylamine oxidation and classified as MAO-preferring (methoxytyramine, tryptamine) or SSAO-preferring substrates (methylamine, octopamine). Short-term incubation with 1 mmol/L of all amines except histamine stimulated glucose uptake up to 20% to 50% of maximal insulin activation. One-week treatment with either MAO or SSAO substrates alone allowed postconfluent cells to differentiate into adipocytes, reproducing 60% of insulin-promoted lipid accumulation. All amines also exerted a slight improvement in the adipogenic action of insulin. Therefore, like SSAO, substrate activation of MAO can interact with adipocyte metabolism by mimicking diverse effects of insulin in addition to preventing tumor necrosis factor alpha-dependent responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979412     DOI: 10.1016/j.metabol.2006.06.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.

Authors:  Valentin Jargaud; Sandy Bour; François Tercé; Xavier Collet; Philippe Valet; Anne Bouloumié; Jean-Claude Guillemot; Pascale Mauriège; Sirpa Jalkanen; Craig Stolen; Marko Salmi; David J Smith; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2020-07-25       Impact factor: 4.158

2.  Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study.

Authors:  Mi-Jeong Lee; Da-Wei Gong; Bryan F Burkey; Susan K Fried
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

3.  Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes.

Authors:  E Wanecq; D Prévot; C Carpéné
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

4.  5-hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation.

Authors:  Sandra Grès; Saioa Gomez-Zorita; Ana Gomez-Ruiz; Christian Carpéné
Journal:  J Neural Transm (Vienna)       Date:  2012-12-28       Impact factor: 3.575

5.  Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice.

Authors:  S Bour; D Prévot; C Guigné; C Stolen; S Jalkanen; P Valet; C Carpéné
Journal:  J Neural Transm (Vienna)       Date:  2007-04-04       Impact factor: 3.575

6.  Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.

Authors:  Zsuzsa Iffiú-Soltész; Josep Mercader; Danielle Daviaud; Jérémie Boucher; Christian Carpéné
Journal:  J Neural Transm (Vienna)       Date:  2011-02-05       Impact factor: 3.575

7.  High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Authors:  Christian Carpéné; Stéphane Schaak; Céline Guilbeau-Frugier; Josep Mercader; Jeanne Mialet-Perez
Journal:  J Physiol Biochem       Date:  2015-12-03       Impact factor: 4.158

8.  High doses of tyramine stimulate glucose transport in human fat cells.

Authors:  Christian Carpéné; Francisco Les; Josep Mercader-Barceló; Nathalie Boulet; Anaïs Briot; Jean-Louis Grolleau
Journal:  J Physiol Biochem       Date:  2022-01-23       Impact factor: 4.158

9.  Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Authors:  Josep Mercader; Zsuzsa Iffiú-Soltész; Sandy Bour; Christian Carpéné
Journal:  J Obes       Date:  2011-02-08

10.  Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet.

Authors:  Z Iffiú-Soltész'; D Prévot; S Grés; S Bour; E Szökö; C Knauf; R Burcelin; A Fernández-Quintela; A Lomba; F I Milagro; C Carpéné
Journal:  J Physiol Biochem       Date:  2007-12       Impact factor: 5.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.